IP Verse

Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus

Patent No. EP3443979 (titled "Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus") was filed by Assistance Publique Hpitaux DE Paris on Mar 9, 2012. The application was issued on May 27, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANFeb 26, 2021MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3443979

ASSISTANCE PUBLIQUE HPITAUX DE PARIS
Application Number
EP18179669A
Filing Date
Mar 9, 2012
Status
Granted And Under Opposition
Apr 24, 2020
Publication Date
May 27, 2020
External Links
Slate, Register , Google Patents